Sign inGet started

Nanda Nisha

Insider CIK 1762683 · LOXO Chief Development Officer · MORF Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
MORF Morphic Holding, Inc. A Award deriv2024-06-042024-06-0523,168— $023,168SEC↗
MORF Morphic Holding, Inc. A Award deriv2023-06-012023-06-0212,535— $012,535SEC↗
MORF Morphic Holding, Inc. A Award deriv2022-06-082022-06-1017,550— $017,550SEC↗
MORF Morphic Holding, Inc. A Award deriv2021-08-192022-04-2918,177— $018,177SEC↗
MORF Morphic Holding, Inc. A Award deriv2021-08-192021-08-2324,000— $024,000SEC↗
LOXO Loxo Oncology, Inc. D To issuer deriv2019-02-152019-02-1514,828$235.00 $3.48M0SEC↗
LOXO Loxo Oncology, Inc. D To issuer deriv2019-02-152019-02-1516,983$235.00 $3.99M0SEC↗
LOXO Loxo Oncology, Inc. D To issuer deriv2019-02-152019-02-154,557$235.00 $1.07M0SEC↗
LOXO Loxo Oncology, Inc. D To issuer deriv2019-02-152019-02-1510,861$235.00 $2.55M0SEC↗
LOXO Loxo Oncology, Inc. D To issuer deriv2019-02-152019-02-159,228$235.00 $2.17M0SEC↗
LOXO Loxo Oncology, Inc. D To issuer deriv2019-02-152019-02-1514,870$235.00 $3.49M0SEC↗
LOXO Loxo Oncology, Inc. D To issuer deriv2019-02-152019-02-1537,000$235.00 $8.70M0SEC↗
LOXO Loxo Oncology, Inc. D To issuer deriv2019-02-152019-02-1518,375$235.00 $4.32M0SEC↗
LOXO Loxo Oncology, Inc. D To issuer deriv2019-02-152019-02-1512,000$235.00 $2.82M0SEC↗
LOXO Loxo Oncology, Inc. D To issuer deriv2019-02-152019-02-1575,000$235.00 $17.63M0SEC↗
LOXO Loxo Oncology, Inc. D To issuer2019-02-152019-02-1518,896$235.00 $4.44M0SEC↗
LOXO Loxo Oncology, Inc. A Award deriv2019-01-022019-01-0237,000— $037,000SEC↗